Short Interest in Guided Therapeutics, Inc. (OTCMKTS:GTHP) Grows By 40.8%

Guided Therapeutics, Inc. (OTCMKTS:GTHP) saw a large increase in short interest in February. As of February 15th, there was short interest totalling 13,800 shares, an increase of 40.8% from the January 31st total of 9,800 shares. Based on an average daily volume of 28,200 shares, the short-interest ratio is currently 0.5 days.

Guided Therapeutics Stock Down 8.9 %

OTCMKTS:GTHP traded down $0.01 during trading hours on Tuesday, reaching $0.10. 28,256 shares of the company’s stock were exchanged, compared to its average volume of 17,319. The company has a market capitalization of $6.25 million, a P/E ratio of -3.19 and a beta of 0.61. Guided Therapeutics has a 12 month low of $0.06 and a 12 month high of $0.23. The business’s 50-day simple moving average is $0.13 and its two-hundred day simple moving average is $0.15.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.